Product Description
144035-83-6 Piclamilast API is a drug that has been investigated for the treatment of asthma and chronic obstructive pulmonary disease (COPD). It refers to the active pharmaceutical ingredient (API) of the medication. The API is the biologically active component of the drug, responsible for its therapeutic effects. It belongs to the class of compounds known as phosphodiesterase inhibitors. This is the compound that directly inhibits phosphodiesterase, thereby exerting its pharmacological actions. 144035-83-6 Piclamilast API undergoes rigorous testing and quality control measures to ensure its purity, potency, and safety before being formulated into finished pharmaceutical products.